Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Global and China Insulin Market to reach US$32.24 Bn by 2019

Author: Akash Pande
by Akash Pande
Posted: Jan 28, 2019

Transparency Market Research has published a new report on the rapid medical diagnostics kits market that discusses its position in the global setting. The research report, titled "Global and China Insulin Market - Industry Analysis, Size, Share, Growth, 2013 - 2019," offers an evaluation of the market in a political, economic, social, technological, legal, and environmental context. The report has also used a SWOT analysis and Porter’s five forces analysis to determine the factors governing the trajectory of this market in the near future.According to research report, the global and China insulin market stood at US$19.99 bn in 2012 and is expected to reach US$32.24 bn by 2019, registering a CAGR of 6.1% between 2013 and 2019. The positive growth in the valuation of the global and China insulin market will be mainly due to the increasing incidence of diabetes and rise in the research and development of insulin across the globe.

The Chinese insulin industry is growing steadily as the type 1 diabetic population that needs insulin to manage the condition continues to grow. The proliferation of this market in China is also attributable to the improving medical infrastructure, changing lifestyles, drastic changes in dietary habits, and increasing preference for fast food.

The global and China insulin market has been segmented on the basis of mode of action and source. Depending on the mode of action, the types of insulin in the market are long-acting, short-acting, rapid-acting, intermediate-acting, and premixed. The sources of insulin are differentiated into human and modern.

Request to View Sample of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=259

The long-acting insulin segment is expected to register a CAGR of 8.7% in the forecast period. This rise in the earnings of the long-acting insulin segment will be mainly be due its advantage of a smaller dosage offering better results as compared to the other types of insulin. The growth of this segment will also be supported by the lack of price restrictions for long-lasting insulin and a strong pipeline of products in the market. The success of long-acting insulin was closely followed by the rapid-acting insulin segment in 2012. In the same year, the premixed insulin segment held a share of more than 50% in the China insulin market.

Some of the important companies profiled in the global rapid medical diagnostic kits market are Trinity Biotech Plc, Alere, Inc., Abbott Laboratories, Abaxis, Inc., Danaher Corporation, BioRad Laboratories, F. Hoffmann La Roche, Becton Dickinson & Company, MegaCor Diagnostik GmbH, MegaCor, and Zoetis, Inc. The research report also explains the competitive landscape in this market by evaluating the financial overview, business and marketing strategies, research and development activities, and investment outlook for the near future.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=259

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

About the Author

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materia

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Akash Pande

Akash Pande

Member since: Jan 03, 2019
Published articles: 1306

Related Articles